Clinical practice guidelines for the management of early breast cancer will assist in the decision making for women with early breast cancer for both health professionals and consumers.
This resource has been superseded in-full or in-part by:
- Guidance for the management of early breast cancer
- Recommendations for the management of early breast cancer in women with an identified BRCA1 or BRCA2 gene mutation or at high risk of a gene mutation
- Aromatase inhibitors adjuvant endocrine therapy post-menopausal receptor-positive early breast cancer
- Recommendations for use of bisphosphonates in early breast cancer
- Recommendations for use of hypofractionated radiotherapy in early (operable) breast cancer
- Recommendations for staging and managing the axilla in early (operable) breast cancer
- Recommendations for follow-up of women with early breast cancer
- Recommendations for use of Taxane-containing chemotherapy regimens for the treatment of early (operable) breast cancer
- Recommendations for use of Sentinel node biopsy in early (operable) breast cancer
| File name: | cpg-clinical-practice-guide...52.pdf |
| File size: | 722.33 KB |
| Cancer Type: | Breast cancer |
| Publication Audience: | Resources for health professionals |
| Year: | 2001 |
| Document Status: | Superseded This resource has been superseded in-full or in-part by an updated version. It is available to the public for research and reference purposes only. Cancer Australia assumes no legal liability or responsibility for errors or omissions contained within. |